Ownership history in UBS Group AG · 14 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in ICECURE MEDICAL LTD CAESAREA (ICCM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 92,165 | +70,523 | +325.9% | 0.00% | $56K | $0.61 |
| 2025 Q3 | ADDED | 21,642 | +6,766 | +45.5% | 0.00% | $22K | $1.01 |
| 2025 Q2 | ADDED | 14,876 | +12,714 | +588.1% | 0.00% | $15K | $1.00 |
| 2025 Q1 | REDUCED | 2,162 | -57,732 | -96.4% | 0.00% | $3K | $1.18 |
| 2024 Q3 | ADDED | 59,894 | +39,060 | +187.5% | 0.00% | $37K | $0.61 |
| 2023 Q4 | ADDED | 20,834 | +6,045 | +40.9% | 0.00% | $22K | $1.07 |
| 2023 Q3 | ADDED | 14,789 | +13,061 | +755.8% | 0.00% | $8K | $0.54 |
| 2023 Q1 | REDUCED | 1,728 | -27,258 | -94.0% | 0.00% | $2K | $1.15 |
| 2022 Q4 | ADDED | 28,986 | +26,919 | +1302.3% | 0.00% | $45K | $1.55 |
| 2022 Q3 | REDUCED | 2,067 | -1,756 | -45.9% | 0.00% | $3K | $1.29 |
As of 2025 Q4 — sorted by position size